Bragar Eagel & Squire, P.C. Is Investigating Cassava, Dentsply Sirona, IonQ, and … | Your Money


NEW YORK, May 22, 2022 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Cassava Sciences, Inc. (NASDAQ: SAVA), Dentsply Sirona, Inc. (NASDAQ: XRAY), IonQ, Inc. (NYSE: IONQ), and Singularity Future Technology, Inc. (NASDAQ: SGLY). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.

Cassava Sciences, Inc. (NASDAQ: SAVA)

On April 18, 2022,  The New York Times  published an article entitled “Scientists Question Data Behind an Experimental Alzheimer’s Drug.”  The article addressed Cassava’s experimental Alzheimer’s drug, simufilam, and…

Read full article at